Abstract
Genetic Engineering & Biotechnology NewsVol. 40, No. 10 Genome EditingGene Therapy Startups Extend Biotech's LegacyBorn 40 years ago when Genentech went public, the biotech industry has engendered multiple disruptions—and another is on its way, driven by gene therapy's resurgenceCatherine ShafferCatherine ShafferSearch for more papers by this authorPublished Online:7 Oct 2020https://doi.org/10.1089/gen.40.10.09AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 40Issue 10Oct 2020 Information© 2020 by GEN PublishingTo cite this article:Catherine Shaffer.Gene Therapy Startups Extend Biotech's Legacy.Genetic Engineering & Biotechnology News.Oct 2020.32, 34, 36.http://doi.org/10.1089/gen.40.10.09Published in Volume: 40 Issue 10: October 7, 2020PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
